Diagnostic usefulness of procalcitonin as a marker of bacteremia in patients with acute pyelonephritis

References

• McMurray BR, Wrenn KD, Wright SW. Usefulness of blood cultures in pyelonephritis. Am J Emerg Med 1997; 15:137–40.
   PubMed Web of Science ®Google Scholar
• Wing DA, Park AS, Debuque L, Millar LK. Limited clinical utility of blood and urine cultures in the treatment of acute pyelonephritis during pregnancy. Am J Obstet Gynecol 2000;182:1437–40.
   PubMed Web of Science ®Google Scholar
• Hsu CY, Fang HC, Chou KJ, Chen CL, Lee PT, Chung HM. The clinical impact of bacteremia in complicated acute pyelonephritis. Am J Med Sci 2006;332:175–80.
   PubMed Web of Science ®Google Scholar
• Guinard-Barbier S, Grabar S, Chenevier-Gobeaux C, Quinquis L, Schmidt J, Kierzek G, Guerin S, Hausfater P, Bernot B, Brun P, Gayet A, Casalino E, Andreotti C, Renaud B, Claessens YE. Is mid-regional pro-atrial natriuretic peptide (MRproANP) an accurate marker of bacteremia in pyelonephritis?Biomarkers 2011;16:355–63.
   PubMed Web of Science ®Google Scholar
• van Nieuwkoop C, Bonten TN, van't Wout JW, Kuijper EJ, Groeneveld GH, Becker MJ, Koster T, Wattel-Louis GH, Delfos NM, Ablij HC, Leyten EM, van Dissel JT. Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study. Crit Care 2010;14:R206.
   PubMed Web of Science ®Google Scholar
• Claessens YE, Schmidt J, Batard E, Grabar S, Jegou D, Hausfater P, Kierzek G, Guerin S, Pourriat JL, Dhainaut JF, Ginsburg C. Can C-reactive protein, procalcitonin and mid-regional pro-atrial natriuretic peptide measurements guide choice of in-patient or out-patient care in acute pyelonephritis?Biomarkers In Sepsis (BIS) multicentre study. Clin Microbiol Infect 2010;16:753–60.
   PubMed Web of Science ®Google Scholar
• Lemiale V, Renaud B, Moutereau S, N’Gako A, Salloum M, Calmettes MJ, Herve J, Boraud C, Santin A, Grego JC, Braconnier F, Roupie E. A single procalcitonin level does not predict adverse outcomes of women with pyelonephritis. Eur Urol 2007;51:1394–401.
   PubMed Web of Science ®Google Scholar
• Limper M, de Kruif MD, Ajubi NE, van Zanten AP, Brandjes DP, Duits AJ, van Gorp EC. Procalcitonin as a potent marker of bacterial infection in febrile Afro- Caribbean patients at the emergency department. Eur J Clin Microbiol Infect Dis 2011;30:831–6.
   PubMed Web of Science ®Google Scholar
• Li CH, Yang RB, Pang JH, Chang SS, Lin CC, Chen CH, Chen HY, Chiu TF. Procalcitonin as a biomarker for bacterial infections in patients with liver cirrhosis in the emergency department. Acad Emerg Med 2011;18:121–6.
   PubMed Web of Science ®Google Scholar
• Caterino JM, Scheatzle MD, Forbes ML, D’Antonio JA. Bacteremic elder emergency department patients: procalcitonin and white count. Acad Emerg Med 2004;11:393–6.
   PubMedGoogle Scholar
• Kim MH, Lim G, Kang SY, Lee WI, Suh JT, Lee HJ. Utility of procalcitonin as an early diagnostic marker of bacteremia in patients with acute fever. Yonsei Med J 2011;52: 276–81.
   PubMed Web of Science ®Google Scholar
• Hantz S, Garnier-Geoffroy F, Mazeron M-C, Garrigue I, Merville P, Mengelle C, Rostaing L, Saint Marcoux F, Essig M, Rerolle J-P, Cotin S, Germi R, Pillet S, Lebranchu Y, Turlure P, Alain S, French CMVRSSG. Drug-resistant cytomegalovirus in transplant recipients: a French cohort study. J Antimicrob Chemother 2010;65:2628–40.
   PubMed Web of Science ®Google Scholar
• Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992;15(Suppl. 1):S216–27.
   Google Scholar
• Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002;137:791–7.
   PubMed Web of Science ®Google Scholar
• da Cunha-Bang C, Iversen M, Mortensen SA, Rasmussen A, Sengelov H, Sorensen SS, Lundgren J. Regarding: Humar. The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transplant 2010;10:1228–1237. Am J Transplantat 2011;11:408.
   PubMed Web of Science ®Google Scholar
• Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 2003;326:41–4.
   PubMed Web of Science ®Google Scholar
• Simel DL, Rennie D, Bossuyt PM. The STARD statement for reporting diagnostic accuracy studies: application to the history and physical examination. J Gen Intern Med 2008; 23:768–74.
   PubMed Web of Science ®Google Scholar
• Perkins NJ, Schisterman EF. The inconsistency of “optimal” cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol 2006;163: 670–5.
   PubMed Web of Science ®Google Scholar
• Deeks JJ, Altman DG. Diagnostic tests 4: likelihood ratios. BMJ 2004;329:168–9.
   PubMed Web of Science ®Google Scholar
• Velasco M, Martinez JA, Moreno-Martinez A, Horcajada JP, Ruiz J, Barranco M, Almela M, Vila J, Mensa J. Blood cultures for women with uncomplicated acute pyelonephritis: are they necessary?Clin Infect Dis 2003;37:1127–30.
   PubMed Web of Science ®Google Scholar
• Chalmers JD, Singanayagam A, Hill AT. C-reactive protein is an independent predictor of severity in community- acquired pneumonia. Am J Med 2008;121:219–25.
   PubMed Web of Science ®Google Scholar
• Povoa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P, Sabino H. C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study. Eur Respir J 2005;25:804–12.
   PubMed Web of Science ®Google Scholar
• Verhagen DW, Hermanides J, Korevaar JC, Bossuyt PM, van den Brink RB, Speelman P, van der Meer JT. Prognostic value of serial C-reactive protein measurements in left-sided native valve endocarditis. Arch Intern Med 2008;168: 302–7.
   PubMedGoogle Scholar
• Ha YE, Kang CI, Joo EJ, Joung MK, Chung DR, Peck KR, Lee NY, Song JH. Usefulness of C-reactive protein for evaluating clinical outcomes in cirrhotic patients with bacteremia. Korean J Intern Med 2011;26:195–200.
   PubMedGoogle Scholar